Welcome to our dedicated page for Nature’S Sun SEC filings (Ticker: NATR), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Want the essentials of Nature’s Sunshine’s direct-selling herbal-supplement business without scrolling through EDGAR? This page gathers every disclosure the company files—whether the next Nature's Sunshine quarterly earnings report 10-Q filing or a sudden 8-K—and puts them in one place. Investors who search phrases like “Nature's Sunshine SEC filings explained simply” or “Nature's Sunshine insider trading Form 4 transactions” find clear answers here. Stock Titan’s AI-powered summaries translate dense language so you spend minutes, not hours, decoding PDFs.
Use intuitive filters to locate the document you need, then let our platform do the reading. Curious whether executives are buying shares? Track Nature's Sunshine Form 4 insider transactions real-time and receive alerts on every Nature's Sunshine executive stock transactions Form 4. Building a model? Each filing comes with an AI brief—your shortcut to Nature's Sunshine earnings report filing analysis that flags segment sales trends, currency swings, and distributor count shifts. When you need the big picture, our digest of the Nature's Sunshine annual report 10-K simplified highlights sourcing risks and product-margin dynamics.
- 10-Q: revenue momentum, inventory levels, and geographic mix
- 10-K: strategic risks around raw-herb sourcing
- 8-K: supply-chain disruptions & leadership updates—Nature's Sunshine 8-K material events explained
- DEF 14A proxy: Nature's Sunshine proxy statement executive compensation comparisons
Because global distributors fuel growth, small regulatory changes can ripple through results. Stock Titan’s expert insights make understanding Nature's Sunshine SEC documents with AI straightforward. Real-time filing alerts combine with historical context so you know when new markets open, pricing shifts hit margins, or management’s pay aligns with performance—all in one continuously updated hub.
Natures Sunshine Products Inc executive Nathan Brower, EVP and General Counsel, reported an in-kind charitable donation of 1,500 common shares of company stock.
The shares were transferred on November 24, 2025 at a reported price of $20.56 per share, the volume-weighted average price that day, and he now holds 45,235 shares directly. The donation was made for charitable purposes and no consideration was received.
Natures Sunshine Products executive Bryant J. Yates reported a disposition of 1,700 common shares on December 12, 2025 at $22.29 per share. After this transaction, he directly owns 98,604 common shares of the company. Yates is listed as Executive Vice President and President, Europe, and the report covers a transaction by a single reporting person.
Nature's Sunshine Products (NATR)11/12/2025, he sold 8,884 common shares at a weighted average price of $20.46 per share, with individual trades ranging from $20.08 to $21.20. On 11/17/2025, he transferred 3,571 common shares as an in-kind charitable donation, for which no consideration was received; the stated price of $20.79 per share reflects the volume-weighted average trading price that day. After these transactions, he beneficially owned 63,065 common shares directly.
Natures Sunshine Products, Inc. (NATR)11/18/2025, he sold 5,000 common shares of NATR in an open-market transaction coded "S" for sale at a price of $20.45 per share. After this transaction, he beneficially owned 46,233 common shares, held directly. The filing was made on Form 4, which is used to disclose changes in ownership by company insiders.
Natures Sunshine Products Inc. (NATR)
Nature’s Sunshine Products (NATR) reported stronger Q3 2025 results, with net sales of
Growth was broad-based: Asia +17.1%, Europe +12.7%, and North America +7.7%, while Latin America and Other declined 13.1%. FX added about
Through September 30, the company repurchased 1,129,000 shares for
Nature’s Sunshine Products, Inc. filed an 8-K announcing it issued a press release with financial results for the first quarter ended September 30, 2025. The release was furnished under Item 2.02 and is attached as Exhibit 99.1.
The company notes the press release includes non-GAAP financial information, with GAAP-to-non‑GAAP reconciliations provided in the release. The information furnished under Item 2.02 is not deemed filed under the Exchange Act.
Nature’s Sunshine Products (NATR) officer Martin A. Gonzalez (EVP, Global Supply Chain) reported RSU-related share activity on 11/04/2025. Two tranches vested and were added at $0 per share via code M: 2,885 shares from a 07/21/2022 performance grant and 2,910 shares from a 04/20/2023 performance grant, each tied to an adjusted EBITDA milestone of $46.2M over a rolling 12 months. To cover taxes (code F), the company withheld 833 and 840 shares at $13.75. Following these transactions, beneficial ownership was 69,640 common shares (direct).
Nature's Sunshine Products (NATR) executive Nathan Brower, EVP and General Counsel, filed a Form 4 reporting equity transactions on 11/04/2025. The filing shows RSU vesting tied to an adjusted EBITDA milestone of $46.2M, resulting in acquisitions of 1,008 and 2,235 common shares at $0.
To cover taxes upon vesting, the company withheld 285 and 700 shares at a price of $13.75. The transactions were reported as Direct ownership and filed by one reporting person.
NATURE’S SUNSHINE (NATR) disclosed an insider equity update: EVP & Chief Financial Officer Leslie Shane Jones reported equity movements on
The vesting reflects achievement of an adjusted EBITDA milestone of